Affiliation:
1. Centre for Biotechnology, Maharshi Dayanand University, Rohtak, Haryana-124001, India
Abstract
Background:
Chemotherapeutic drugs are principally intended to treat breast cancer. However, sooner or later in tumor drug resistance developed. These chemo drugs are effectual, but with numerous side effects. Breast cancer care may be extremely difficult since recurring cancer is frequently pre-treated with powerful agents, and cancer cells acquire high resistance to earlier therapies, necessitating the use of alternative and more powerful drugs. Nanoparticles(NPs) as a medication delivery technology can overcome medication resistance in breast cancer and significantly reduce the effective dose. The off-targeted nature of chemo drugs can be resolved by encapsulating or attaching chemo drugs in nanocarrier which targets specifically breast cancer cells.
Objectives:
In this review, we highlight various chemo drugs for breast cancer and their encapsulation or bioconjugation with nanoparticles for its targeted delivery.
Conclusion:
Nanoparticles may subsist valuable abet in breast cancer management in this regard. Given that traditional chemotherapy, approaches have been demonstrated to have several side effects and defects during treatment, the NPs-mediated Drug delivery mechanism is a possible contender for replacement as a new technique.
Funder
Womens’ Scientist Scheme from the Department of Science and Technology
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology (medical),Cancer Research,Drug Discovery,Oncology,General Medicine
Reference141 articles.
1. Torre L.A.; Siegel R.L.; Ward E.M.; Jemal A.; Global cancer incidence and mortality rates and trends: an update. Cancer Epidemiol Biomarkers Prev 2016,25(1),16-27
2. Hassan M.S.U.; Ansari J.; Spooner D.; Hussain S.A.; Chemotherapy for breast cancer. (Review) Oncol Rep 2010,24(5),1121-1131
3. Chew H.K.; Adjuvant therapy for breast cancer: who should get what? West J Med 2001,174(4),284-287
4. Untch M.; Konecny G.E.; Paepke S.; von Minckwitz G.; Current and future role of neoadjuvant therapy for breast cancer. Breast 2014,23(5),526-537
5. Schirrmacher V.; From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment. (Review) Int J Oncol 2019,54(2),407-419
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献